Skip to Main Content

Paper Details

Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses.
Front Immunol
2
2021
56.a.09, B cells, B-cell transcripts, HV6-1-class antibodies, Human, Influenza A Viruses, MEDI8852, amino acid, hemagglutinin, human, influenza A, influenza A viruses
Author NameAffiliation
Gwo-Yu ChuangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Chen-Hsiang ShenVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Michael G JoyceVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Reda RawiVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Lingshu WangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Yongping YangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Baoshan ZhangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Tongqing ZhouVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
John R MascolaVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Peter D KwongVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • 1 - 10

Datasets

Release 1.2